vs
Side-by-side financial comparison of Dexcom (DXCM) and MSCI Inc. (MSCI). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $822.5M, roughly 1.5× MSCI Inc.). MSCI Inc. runs the higher net margin — 34.6% vs 21.2%, a 13.4% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 10.6%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 10.0%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
MSCI Inc. is an American finance company headquartered in New York City. MSCI is a global provider of equity, fixed income, real estate indices, multi-asset portfolio analysis tools, ESG and climate finance products. It operates the MSCI World, MSCI Emerging Markets, and MSCI All Country World (ACWI) indices, among others.
DXCM vs MSCI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $822.5M |
| Net Profit | $267.3M | $284.7M |
| Gross Margin | 62.9% | — |
| Operating Margin | 25.6% | 56.4% |
| Net Margin | 21.2% | 34.6% |
| Revenue YoY | 21.6% | 10.6% |
| Net Profit YoY | 153.6% | -6.8% |
| EPS (diluted) | $0.67 | $3.81 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $822.5M | ||
| Q3 25 | $1.2B | $793.4M | ||
| Q2 25 | $1.2B | $772.7M | ||
| Q1 25 | $1.0B | $745.8M | ||
| Q4 24 | $1.1B | $743.5M | ||
| Q3 24 | $994.2M | $724.7M | ||
| Q2 24 | $1.0B | $707.9M |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $284.7M | ||
| Q3 25 | $283.8M | $325.4M | ||
| Q2 25 | $179.8M | $303.6M | ||
| Q1 25 | $105.4M | $288.6M | ||
| Q4 24 | $151.7M | $305.5M | ||
| Q3 24 | $134.6M | $280.9M | ||
| Q2 24 | $143.5M | $266.8M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 56.4% | ||
| Q3 25 | 20.1% | 56.4% | ||
| Q2 25 | 18.4% | 55.0% | ||
| Q1 25 | 12.9% | 50.6% | ||
| Q4 24 | 17.0% | 54.5% | ||
| Q3 24 | 15.3% | 55.4% | ||
| Q2 24 | 15.7% | 54.0% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 34.6% | ||
| Q3 25 | 23.5% | 41.0% | ||
| Q2 25 | 15.5% | 39.3% | ||
| Q1 25 | 10.2% | 38.7% | ||
| Q4 24 | 13.6% | 41.1% | ||
| Q3 24 | 13.5% | 38.8% | ||
| Q2 24 | 14.3% | 37.7% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $3.81 | ||
| Q3 25 | $0.70 | $4.25 | ||
| Q2 25 | $0.45 | $3.92 | ||
| Q1 25 | $0.27 | $3.71 | ||
| Q4 24 | $0.37 | $3.89 | ||
| Q3 24 | $0.34 | $3.57 | ||
| Q2 24 | $0.35 | $3.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $515.3M |
| Total DebtLower is stronger | — | $6.2B |
| Stockholders' EquityBook value | $2.7B | $-2.7B |
| Total Assets | $6.3B | $5.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $515.3M | ||
| Q3 25 | $1.8B | $400.1M | ||
| Q2 25 | $1.2B | $347.3M | ||
| Q1 25 | $904.9M | $360.7M | ||
| Q4 24 | $606.1M | $409.4M | ||
| Q3 24 | $621.2M | $501.0M | ||
| Q2 24 | $939.2M | $451.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | $6.2B | ||
| Q3 25 | — | $5.5B | ||
| Q2 25 | — | $4.5B | ||
| Q1 25 | — | $4.5B | ||
| Q4 24 | — | $4.5B | ||
| Q3 24 | — | $4.5B | ||
| Q2 24 | — | $4.5B |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $-2.7B | ||
| Q3 25 | $2.7B | $-1.9B | ||
| Q2 25 | $2.6B | $-886.2M | ||
| Q1 25 | $2.3B | $-958.6M | ||
| Q4 24 | $2.1B | $-940.0M | ||
| Q3 24 | $2.0B | $-751.0M | ||
| Q2 24 | $2.4B | $-734.5M |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $5.7B | ||
| Q3 25 | $7.5B | $5.4B | ||
| Q2 25 | $7.3B | $5.4B | ||
| Q1 25 | $6.8B | $5.3B | ||
| Q4 24 | $6.5B | $5.4B | ||
| Q3 24 | $6.4B | $5.4B | ||
| Q2 24 | $6.8B | $5.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $501.1M |
| Free Cash FlowOCF − Capex | — | $488.7M |
| FCF MarginFCF / Revenue | — | 59.4% |
| Capex IntensityCapex / Revenue | — | 1.5% |
| Cash ConversionOCF / Net Profit | — | 1.76× |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.5B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $501.1M | ||
| Q3 25 | $659.9M | $449.4M | ||
| Q2 25 | $303.0M | $336.1M | ||
| Q1 25 | $183.8M | $301.7M | ||
| Q4 24 | $301.4M | $430.6M | ||
| Q3 24 | $199.5M | $421.6M | ||
| Q2 24 | $279.4M | $349.2M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $488.7M | ||
| Q3 25 | $579.4M | $445.5M | ||
| Q2 25 | $208.9M | $324.7M | ||
| Q1 25 | $96.8M | $290.2M | ||
| Q4 24 | $176.8M | $416.4M | ||
| Q3 24 | $88.3M | $415.0M | ||
| Q2 24 | $213.3M | $340.6M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 59.4% | ||
| Q3 25 | 47.9% | 56.2% | ||
| Q2 25 | 18.1% | 42.0% | ||
| Q1 25 | 9.3% | 38.9% | ||
| Q4 24 | 15.9% | 56.0% | ||
| Q3 24 | 8.9% | 57.3% | ||
| Q2 24 | 21.2% | 48.1% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 1.5% | ||
| Q3 25 | 6.7% | 0.5% | ||
| Q2 25 | 8.1% | 1.5% | ||
| Q1 25 | 8.4% | 1.5% | ||
| Q4 24 | 11.2% | 1.9% | ||
| Q3 24 | 11.2% | 0.9% | ||
| Q2 24 | 6.6% | 1.2% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 1.76× | ||
| Q3 25 | 2.33× | 1.38× | ||
| Q2 25 | 1.69× | 1.11× | ||
| Q1 25 | 1.74× | 1.05× | ||
| Q4 24 | 1.99× | 1.41× | ||
| Q3 24 | 1.48× | 1.50× | ||
| Q2 24 | 1.95× | 1.31× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
MSCI
| Recurring Subscriptions | $246.4M | 30% |
| Asset Based Fees | $211.7M | 26% |
| Analytics Segment | $182.3M | 22% |
| Sustainability And Climate Segment | $90.3M | 11% |
| Other | $70.9M | 9% |
| Non Recurring | $21.1M | 3% |
